Medartis Holding AG
MDRSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6% | 16% | 14.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 79.5% | 79% | 74.1% | 76% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | -$0 | $0 |
| % Margin | 3.5% | 4.3% | -1% | 6.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | $0 |
| Tax Expense | -$0 | $0 | -$0 | $0 |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 1.6% | 0.3% | -3.2% | 4.3% |
| EPS | 0.26 | 0.051 | -0.49 | 0.58 |
| % Growth | 413.8% | 110.3% | -184.5% | – |
| EPS Diluted | 0.26 | 0.051 | -0.49 | 0.58 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13.4% | 11.6% | 8.9% | 15.9% |